Quality is Life — Laos Alliance Pharmaceutical Group

ລາວ/中文/EN

Manufacturing & innovation

Manufacturing Capabilities

Every dosage form we make

Manufacturing Network

Plants & 20 workshops

Research & Development

Labs, ATMP & formulation

Quality & GMP

Standards & traceability

Alliance Regenerative Centre

Stem-cell, NK & exosome science

Integrated Value Chain

Farm → chemicals → finished

What we make

Every major dosage form, made to one GMP standard

Explore capabilities

/

NEWSROOM

Biotechnology

ALI-LENA® Injection (lenacapavir) registered in Lao PDR

The Food and Drug Department has registered ALI-LENA® Injection (lenacapavir) 463.5 mg / 1.5 mL for subcutaneous use, indicated with other antiretrovirals for heavily treatment-experienced adults with multidrug-resistant HIV-1.

A Driving Force in Southeast Asian Pharmaceutical Manufacturing

Alliance’s first-half 2026 highlights, from ASEAN expansion to advanced biopharmaceutical manufacturing.

ALIVOSO® (vosoritide) registered in Lao PDR

The Food and Drug Department has registered ALIVOSO® (vosoritide) 1.2 mg powder for injection, indicated to increase linear growth in children with achondroplasia whose growth plates have not closed.